Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NRIX

Nurix Therapeutics Inc

May 13 • 04:00PM ET

16.18

+0.22 1.38 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR ARVN CCCC GLUE RLAY

| Held by: XBI VTI IWM ARKG VXF IWN IBB VTWO SCHA DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.16	Insider Own	5.86%	Shs Outstand	103.40M	Perf Week	-4.15%
Market Cap	1.67B	Forward P/E	-	EPS next Y	-2.83	Insider Trans	-2.02%	Shs Float	97.35M	Perf Month	-0.74%
Enterprise Value	1.19B	PEG	-	EPS next Q	-0.72	Inst Own	105.03%	Short Float	19.72%	Perf Quarter	0.43%
Income	-295.28M	P/S	23.31	EPS this Y	3.26%	Inst Trans	35.60%	Short Ratio	17.91	Perf Half Y	32.08%
Sales	71.78M	P/B	3.48	EPS next Y	3.94%	ROA	-47.20%	Short Interest	19.20M	Perf YTD	-14.71%
Book/sh	4.65	P/C	3.09	EPS next 5Y	9.58%	ROE	-61.40%	52W High	22.50 -28.09%	Perf Year	66.29%
Cash/sh	5.23	P/FCF	-	EPS past 3/5Y	6.31% -2.04%	ROIC	-55.05%	52W Low	8.19 97.44%	Perf 3Y	56.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.55% 36.35%	Gross Margin	74.22%	Volatility	4.52% 4.50%	Perf 5Y	-35.79%
Dividend TTM	-	EV/Sales	16.59	EPS Y/Y TTM	-12.53%	Oper. Margin	-439.26%	ATR (14)	0.80	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.01	Sales Y/Y TTM	27.23%	Profit Margin	-411.37%	RSI (14)	47.62	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	6.01	EPS Q/Q	-17.44%	SMA20	-2.79%	Beta	1.86	Target Price	30.18
Payout	-	Debt/Eq	0.12	Sales Q/Q	-66.12%	SMA50	1.39%	Rel Volume	0.91	Prev Close	15.96
Employees	317	LT Debt/Eq	0.12	Earnings	Apr 08 BMO	SMA200	13.18%	Avg Volume	1.07M	Price	16.18
IPO	Jul 24, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.59% -56.13%	Trades		Volume	979,107	Change	1.38%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)